MedAvail Holdings, Inc.

MedAvail Holdings, Inc.

MDVLQ
MedAvail Holdings, Inc.US flagOther OTC
0.00
USD
- -
- -
161.00Market Cap
MedAvail Holdings, Inc.
MDVLQ
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2019
2020
2021
2022
TTM
FRC
5.95
122.06
33.88
32.77
14.43
Revenue per Share
-34
-234.27
-67.09
-36.2
-27.85
Basic EPS, GAAP
-31.49
-257.35
-70.14
-37.98
-19.51
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
Dividend per Share
-191.39
-1,295.38
-294.06
-182.15
-159.13
Book Value per Share
-152.7
531.63
25.68
15.48
13.55
Tangible Book Value per Share
1
- -
1
1
2
Basic Weighted Avg Shares
4
14
22
43
24
Sales/Revenue/Turnover
-549.11
-148.99
-196.62
-107.69
-132.99
Operating Margin (%)
2
2
3
5
5
Depreciation Expense
-22
-27
-44
-48
-46
Net Income, GAAP
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-571.02
-191.94
-198
-110.45
-192.97
Profit Margin (%)
6
56
20
18
23
Working Capital
13
1
12
6
2
LT Debt
-97
61
19
21
23
Total Equity
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Dec'22
Mar'23
Jun'23
ST Debt
1
- -
- -
LT Borrowings
5
1
2
LT Finance Leases
2
1
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
2
2
2
Market Capitalization
20
22
20

Working Capital

FRC

in mil. unless spec.
Dec'22
Mar'23
Jun'23
Total Current Assets
24
33
27
Cash, Cash Equivalents & STI
11
19
14
Accounts Receivable, Net
2
- -
- -
Inventories
7
9
10
Total Current Liabilities
6
5
4
Payables & Accruals
5
3
2
ST Debt
1
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
9.18%
Free Cash Flow
- -
- -
9.08%
Net Income, GAAP
- -
- -
8.68%
Sales/Revenue/Turnover
- -
- -
94.81%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
4
5
6
7
22
2022
- -
1
11
11
43
2023
1
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
-14.57
-16.08
-17.21
-19.22
-67.09
2022
-19.78
-8.45
-7.37
-6.91
-36.2
2023
-10.79
-3.22
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
Business
MedAvail Holdings, Inc. is a technology-enabled retail pharmacy technology and services company operating primarily in the United States and Canada. The company develops and commercializes self-service pharmacy, mobile application, and kiosk solutions designed to provide on-site pharmacy services in medical clinics, retail stores, employer sites, and other locations where direct prescription dispensing is required. Its core product offering includes the MedAvail MedCenter, a pharmacy technology solution that enables prescription drug dispensing through an audio-visual connection to a live pharmacist, ensuring real-time supervision and interaction. The company also operates SpotRx, a full-service retail pharmacy utilizing MedAvail’s automated pharmacy technology primarily catering to Medicare patients. MedAvail’s latest major changes involve a strategic restructuring announced in 2025 to focus exclusively on its pharmacy technology business, with plans to exit its pharmacy services segment, including SpotRx. This shift reflects a strategic prioritization of developing and expanding its MedCenter kiosk technology. In 2023 and early 2024, MedAvail entered multiple deployment agreements, including significant contracts with Oak Lawn Pharmacy and St. Thomas Community Health Centers for the installation of M4 MedCenters in various locations. However, the company faced financial challenges, including a voluntary Chapter 7 liquidation filing in early 2024 and staff reductions of approximately 40% to manage operating expenses. It also raised funds through private placements in recent years to support restructuring and operational costs. Founded in 2006 and headquartered in Phoenix, Arizona, MedAvail operates in two core segments: Retail Pharmacy Services and Pharmacy Technology. Its pharmacy technology segment involves the direct sale or leasing of the MedCenter kiosks to third-party customers, while its retail services segment operates through SpotRx. The company’s technology is targeted at healthcare providers, retail chains, employers, and medical clinics seeking innovative pharmacy delivery and telehealth solutions. MedAvail has maintained focus on technological innovation in automated medication dispensing and telepharmacy, aiming to enhance medication adherence and patient access to pharmacy services. MedAvail Holdings’s strategic shift toward pharmacy technology and recent partnerships emphasize its commitment to expanding the footprint of its automated dispensing solutions while managing liquidity and operational efficiency amidst financial restructuring efforts. The company continues to leverage its platform to address evolving needs in the healthcare and retail pharmacy markets across North America.